Evidence map›Paper›PMID 27148961›Full record

ArticleMolecular carcinogenesis2017

Polyubiquitination of apurinic/apyrimidinic endonuclease 1 by Parkin.

Timothy L Scott, Christina A Wicker, Rangaswamy Suganya, Bithika Dhar, Thomas Pittman, Craig Horbinski, Tadahide Izumi

Open access · greenAbstract read
In one paragraph

Article in Molecular carcinogenesis, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.0field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Timothy L ScottDepartment of Toxicology and Cancer Biology, University of Kentucky, Lexington, Kentucky.
Christina A WickerDepartment of Toxicology and Cancer Biology, University of Kentucky, Lexington, Kentucky.
Rangaswamy SuganyaRadiation Oncology, Houston Methodist Research Institute, Houston, Texas.
Bithika DharDepartment of Toxicology and Cancer Biology, University of Kentucky, Lexington, Kentucky.
Thomas PittmanDepartment of Neurosurgery, University of Kentucky, Lexington, Kentucky.
Craig HorbinskiDepartments of Pathology and Neurosurgery, Northwestern University, Chicago, Illinois.
Tadahide IzumiDepartment of Toxicology and Cancer Biology, University of Kentucky, Lexington, Kentucky.
University of Kentucky · USHouston Methodist · USNorthwestern University · US

Funding

University of Kentucky Markey Cancer Center Support Grant ECIA SupplementP30CA177558 · NCI · UNIVERSITY OF KENTUCKY · PI Bernard Mark Evers · 2013 to 2026
$38.3M
TRAINING GRANT IN MOLECULAR MECHANISMS OF TOXICITY.T32ES007266 · NIEHS · UNIVERSITY OF KENTUCKY · PI LIU, XIAOQI, MELLON, ISABEL W · 1990 to 2020
$3.7M
Repair of oxidative DNA damage in mammalian cellsR01CA098664 · NCI · UNIVERSITY OF TEXAS MEDICAL BR GALVESTON · PI IZUMI, TADAHIDE · 2003 to 2013
$2.4M
Repair of oxidative DNA damage in mammalian cellsR56CA098664 · NCI · LSU HEALTH SCIENCES CENTER · PI IZUMI, TADAHIDE · 2008 to 2008
$227k
NCI NIH HHS P30 CA177558NCI NIH HHS R01 CA098664NCI NIH HHS R56 CA098664NIEHS NIH HHS T32 ES007266
6 · The paper itself

Abstract

Apurinic/apyrimidinic endonuclease 1 (APE1) is an essential protein crucial for repair of oxidized DNA damage not only in genomic DNA but also in mitochondrial DNA. Parkin, a tumor suppressor and Parkinson's disease (PD) associated gene, is an E3 ubiquitin ligase crucial for mitophagy. Although DNA damage is known to induce mitochondrial stress, Parkin's role in regulating DNA repair proteins has not been elucidated. In this study, we examined the possibility of Parkin-dependent ubiquitination of APE1. Ectopically expressed APE1 was degraded by Parkin and PINK1 via polyubiquitination in mouse embryonic fibroblast cells. PD-causing mutations in Parkin and PINK1 abrogated APE1 ubiquitination. Interaction of APE1 with Parkin was observed by co-immunoprecipitation, proximity ligation assay, and co-localization in the cytoplasm. N-terminal deletion of 41 amino acid residues in APE1 significantly reduced the Parkin-dependent APE1 degradation. These results suggested that Parkin directly ubiquitinated N-terminal Lys residues in APE1 in the cytoplasm. Modulation of Parkin and PINK1 activities under mitochondrial or oxidative stress caused moderate but statistically significant decrease of endogenous APE1 in human cell lines including SH-SY5Y, HEK293, and A549 cells. Analyses of glioblastoma tissues showed an inverse relation between the expression levels of APE1 and Parkin. These results suggest that degradation of endogenous APE1 by Parkin occur when cells are stressed to activate Parkin, and imply a role of Parkin in maintaining the quality of APE1, and loss of Parkin may contribute to elevated APE1 levels in glioblastoma. © 2016 Wiley Periodicals, Inc.

Indexed as

UbiquitinationA549 CellsDNA-(Apurinic or Apyrimidinic Site) LyaseDNA RepairHEK293 CellsHumansProtein Interaction MapsProtein KinasesProteolysisPTEN-Induced Putative KinaseUbiquitin-Protein LigasesAPEX1 protein, humanDNA-(Apurinic or Apyrimidinic Site) Lyaseparkin proteinProtein KinasesPTEN-Induced Putative KinaseUbiquitin-Protein LigasesAPE1DNA repairglioblastomaParkinubiquitination

Identifiers

PMID27148961
PMCPMC5379662
OpenAlexW2464268084

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.